Wave Life Sciences Ltd. (NASDAQ: WVE) kicked off on Friday, up 3.37% from the previous trading day, before settling in for the closing price of $8.02. Over the past 52 weeks, WVE has traded in a range of $3.50-$9.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 610.91% over the past five years. While this was happening, its average annual earnings per share was recorded -94.65%. With a float of $101.38 million, this company’s outstanding shares have now reached $119.16 million.
Let’s look at the performance matrix of the company that is accounted for 268 employees.
Wave Life Sciences Ltd. (WVE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd. is 20.83%, while institutional ownership is 73.39%. The most recent insider transaction that took place on Sep 25 ’24, was worth 154,314. In this transaction Chief Financial Officer of this company sold 17,146 shares at a rate of $9.00, taking the stock ownership to the 19,777 shares. Before that another transaction happened on Sep 25 ’24, when Company’s Officer proposed sale 17,146 for $9.00, making the entire transaction worth $154,314.
Wave Life Sciences Ltd. (WVE) Latest Financial update
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.07 earnings per share (EPS), higher than consensus estimate (set at -0.18) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -94.65% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd.’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Wave Life Sciences Ltd. (NASDAQ: WVE) saw its 5-day average volume 7.42 million, a positive change from its year-to-date volume of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 67.69%. Additionally, its Average True Range was 0.64.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 71.25%, which indicates a significant increase from 64.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 196.72% in the past 14 days, which was higher than the 96.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.03, while its 200-day Moving Average is $5.51. Nevertheless, the first resistance level for the watch stands at $8.45 in the near term. At $8.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.79. If the price goes on to break the first support level at $8.11, it is likely to go to the next support level at $7.94. The third support level lies at $7.77 if the price breaches the second support level.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 1.06 billion has total of 122,475K Shares Outstanding. Its annual sales at the moment are 113,310 K in contrast with the sum of -57,510 K annual income. Company’s last quarter sales were recorded 19,690 K and last quarter income was -32,920 K.
